Portal Venous Pulsatility Index: A Novel Biomarker for Diagnosis of High-Risk Nonalcoholic Fatty Liver Disease-Reference-Cited by-同舟云学术

Portal Venous Pulsatility Index: A Novel Biomarker for Diagnosis of High-Risk Nonalcoholic Fatty Liver Disease

Published:2020-04 Issue:4 Volume:214 Page:786-791
ISSN:0361-803X
Container-title:American Journal of Roentgenology
language:en
Short-container-title:American Journal of Roentgenology

Author:

Baikpour Masoud¹,Ozturk Arinc¹,Dhyani Manish²,Mercaldo Nathaniel D.³,Pierce Theodore T.¹,Grajo Joseph R.⁴,Samir Anthony E.¹

Affiliation:

1. Department of Radiology, Center for Ultrasound Research and Translation, Massachusetts General Hospital, 101 Merrimac St, 3rd Fl, Boston, MA 02114.

2. Lahey Hospital and Medical Center, Burlington, MA.

3. Department of Radiology, Massachusetts General Hospital, Boston, MA.

4. Department of Radiology, University of Florida, Gainesville, FL.

Publisher

American Roentgen Ray Society

Subject

Radiology, Nuclear Medicine and imaging,General Medicine

Link

https://www.ajronline.org/doi/pdf/10.2214/AJR.19.21963

Reference32 articles.

1. The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

2. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes

3. Fibrosis stage is the strongest predictor for disease-specific mortality in NAFLD after up to 33 years of follow-up

4. Pathologic criteria for nonalcoholic steatohepatitis: Interprotocol agreement and ability to predict liver-related mortality

5. Design and validation of a histological scoring system for nonalcoholic fatty liver disease

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global epidemiology of type 2 diabetes in patients with NAFLD or MAFLD: a systematic review and meta-analysis;BMC Medicine;2024-03-06

2. The Portal Venous Pulsatility Index and Main Portal Vein Diameter as Surrogate Markers for Liver Fibrosis in Nonalcoholic Fatty Liver Disease and Metabolic-Dysfunction-Associated Steatotic Liver Disease;Diagnostics;2024-02-11

3. The Future Is Beyond Bright: The Evolving Role of Quantitative US for Fatty Liver Disease;Radiology;2023-11-01

4. Effects of oral propranolol on the resistive and pulsatility indices of major abdominal vasculatures in domestic short‐haired cats;Veterinary Medicine and Science;2023-06-13

5. Variation in hepatic segmental portal venous pulsed wave Doppler flow distribution in patients with NAFLD: A pilot study;Ultrasound;2023-03-22